FdaApplication
ANDA 220271
Identifiers
- fda_app_no: ANDA220271
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMS |
| application_type | ANDA |
| approval_date | 2026-06-11 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 10MG/5ML | SYRUP;ORAL |
1 product